Literature DB >> 15860352

Molecular characterization of a consistent 4.5-megabase deletion at 4q28 in prostate cancer cells.

Sei-Ichi Matsui1, Jeffrey LaDuca, Michael R Rossi, Norma J Nowak, John K Cowell.   

Abstract

Spectral karyotyping of prostate cell lines LNCaP, DU145, PC3, and 22RV demonstrated structural chromosome rearrangements involving the distal long arm of chromosome 4. In all but 22RV, these are nonreciprocal translocations between chromosomes 4 and 10. In 22RV, an apparently reciprocal t(2q;4q) is seen. Fluorescence in situ hybridization analysis of the chromosome 4 translocation breakpoints demonstrated that deletions were associated with all of the translocations, resulting in a net loss of chromosome material. Overlapping deletions in 4q28 approximately 34 were seen in LNCap, DU145, and 22RV, which defined an approximately 4.5-megabase pair common region of deletion. The deletion in PC3 was more proximal on 4q, involving the 4q21 approximately q26 region. A meta analysis of high-resolution definition of losses of chromosome material from published studies demonstrates that loss of 4q material may occur in at least 50% of primary tumors. This analysis defines a series of genes in the critical 4q region, which is potentially associated with prostate tumor development.

Entities:  

Mesh:

Year:  2005        PMID: 15860352     DOI: 10.1016/j.cancergencyto.2004.09.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Identification of Fat4 as a candidate tumor suppressor gene in breast cancers.

Authors:  Chao Qi; Yiwei Tony Zhu; Liping Hu; Yi-Jun Zhu
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

2.  Genome abnormalities precede prostate cancer and predict clinical relapse.

Authors:  Yan P Yu; Chi Song; George Tseng; Bao Guo Ren; William LaFramboise; George Michalopoulos; Joel Nelson; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-05-07       Impact factor: 4.307

3.  Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.

Authors:  R P M Brosens; E J T H Belt; J C Haan; T E Buffart; B Carvalho; H Grabsch; P Quirke; M A Cuesta; A F Engel; B Ylstra; G A Meijer
Journal:  Cell Oncol (Dordr)       Date:  2011-06-30       Impact factor: 6.730

4.  Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes.

Authors:  Yan P Yu; Silvia Liu; Zhiguang Huo; Amantha Martin; Joel B Nelson; George C Tseng; Jian-Hua Luo
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

5.  Bridge-induced chromosome translocation in yeast relies upon a Rad54/Rdh54-dependent, Pol32-independent pathway.

Authors:  Valentina Tosato; Sabrina Sidari; Carlo V Bruschi
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

6.  Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4.

Authors:  H Lu; J Sun; F Wang; L Feng; Y Ma; Q Shen; Z Jiang; X Sun; X Wang; H Jin
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.